Trial intelligence / Profile preview

COMBIVAR smoking cessation trial

2011-004692-36Phase 3Active

Sponsor
Bellvitge University Hospital
Start
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of varenicline, nicotine in nicotine dependence, sponsored by Bellvitge University Hospital. Started Oct 2011; status: active.

02

Drugs

vareniclinenicotine
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2011-004692-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004692-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call